Related Experiment Video
Updated: Apr 19, 2026
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
The diagnosis and management of mild cognitive impairment: a clinical review
Kenneth M Langa1, Deborah A Levine2
1Division of General Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor2Veterans Affairs Center for Clinical Management Research, Ann Arbor, Michigan3Institute for Social Research, University of Michigan, Ann Arbor4Institute of Ge.
Importance:
Cognitive decline is a common and feared aspect of aging. Mild cognitive impairment (MCI) is defined as the symptomatic predementia stage on the continuum of cognitive decline, characterized by objective impairment in cognition that is not severe enough to require help with usual activities of daily living.
Objective:
To present evidence on the diagnosis, treatment, and prognosis of MCI and to provide physicians with an evidence-based framework for caring for older patients with MCI and their caregivers.
Evidence Acquisition:
We searched PubMed for English-language articles in peer-reviewed journals and the Cochrane Library database from inception through July 2014. Relevant references from retrieved articles were also evaluated.
Findings:
The prevalence of MCI in adults aged 65 years and older is 10% to 20%; risk increases with age and men appear to be at higher risk than women. In older patients with MCI, clinicians should consider depression, polypharmacy, and uncontrolled cardiovascular risk factors, all of which may increase risk for cognitive impairment and other negative outcomes. Currently, no medications have proven effective for MCI; treatments and interventions should be aimed at reducing cardiovascular risk factors and prevention of stroke. Aerobic exercise, mental activity, and social engagement may help decrease risk of further cognitive decline. Although patients with MCI are at greater risk for developing dementia compared with the general population, there is currently substantial variation in risk estimates (from <5% to 20% annual conversion rates), depending on the population studied. Current research targets improving early detection and treatment of MCI, particularly in patients at high risk for progression to dementia.
Conclusions And Relevance:
Cognitive decline and MCI have important implications for patients and their families and will require that primary care clinicians be skilled in identifying and managing this common disorder as the number of older adults increases in coming decades. Current evidence supports aerobic exercise, mental activity, and cardiovascular risk factor control in patients with MCI.
Insights
Mild cognitive impairment (MCI) affects 10-20% of older adults. Lifestyle interventions like exercise and managing cardiovascular health may slow cognitive decline, but no medications are currently effective.
Area of Science:
- Gerontology
- Neurology
- Public Health
Background:
- Cognitive decline is a significant concern in aging populations.
- Mild cognitive impairment (MCI) represents a predementia stage characterized by objective cognitive deficits.
- MCI does not impede daily activities but signifies an increased risk for dementia.
Purpose of the Study:
- To review evidence on the diagnosis, treatment, and prognosis of MCI.
- To offer physicians a framework for managing older adults with MCI and their caregivers.
- To highlight the growing importance of MCI identification and management in primary care.
Main Methods:
- Systematic literature search of PubMed and Cochrane Library databases.
- Inclusion of English-language, peer-reviewed articles.
- Evaluation of references from retrieved articles.
Main Results:
- MCI prevalence in adults 65+ is 10-20%, increasing with age; men are at higher risk.
- Factors like depression, polypharmacy, and cardiovascular risks exacerbate MCI.
- No current medications are effective; focus is on cardiovascular risk reduction and stroke prevention.
- Aerobic exercise, mental activity, and social engagement may mitigate cognitive decline.
- Annual dementia conversion rates vary (5-20%), with ongoing research for early detection and high-risk patient treatment.
Conclusions:
- MCI has significant implications for patients and families.
- Primary care clinicians need expertise in identifying and managing MCI.
- Evidence supports lifestyle interventions (aerobic exercise, mental activity) and cardiovascular risk control for MCI patients.
More Related Videos
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
07:42Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
Published on: December 16, 2022
Related Concept Videos
01:26Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
01:22Alzheimer's Disease: Treatment
01:22Dementia l: Introduction
01:30Dementia
The progression of dementia is generally gradual....
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
01:30Cognitive Development During Adulthood